Logo KMS TEAM
Precise execution

MC Services is...

Client News

 

 

… an international Corporate Communications and Investor Relations firm providing high-level consultancy with targeted services and support for transaction-oriented assignments throughout Europe and the United States.

 

Read more

 

MC Services successfully attended a variety of conferences in the first months of 2017

 

With participation in a number of conferences all over Europe, MC Services made a successful start into 2017. For a list of attended conferences and some impressions visit us on Facebook.

 

Read more

 

MC Services AG is supporting BIO-Europe & German Equity Forum as media partner

 

BIO-Europe 2017 

 

Organized by EBD Group, the 23rd annual BIO-Europe will this year take place in Berlin, Germany, from November 6 to 8, 2017. As Europe's largest life science partnering conference, BIO-Europe is the "must-attend" event offering opportunities for those involved in the biotech industry to network, bringing together hundreds of the world’s most innovative leaders across biotech, finance and pharma for high-level networking, pre-scheduled partnering meetings, strategic panel discussions and more.

 

As media partner, MC Services invites both local and international journalist to the event and keeps them informed on the presenting company executives and attending investors. Additional Information on MC Services’ engagement and activities during the conference will be announced soon.

 

Learn more


German Equity Forum 2017

 

MC Services AG is again supporting this year’s German Equity Forum, taking place from November 27-29, as media partner.  According to the slogan "Entrepreneurs meet investors" the Deutsche Börse AG has organized the German Equity Forum since 1996, which has evolved into one of the most important and significant capital market events in corporate finance in Europe. Last year alone, around 3,000 1on1 meetings and 200 analysts' conferences took place. The 3-day program features panel discussions, presentations and workshops on current market developments in corporate financing and the capital market.

 

Learn more

Adocia presents first half 2017 financial results 

www.adocia.com

Humabs BioMed and University of California, Berkeley Announce Publication of Data for Novel Antibody-based Assay  to Detect Zika Virus Infection

www.humabs.com

Amendment to Amphion Innovations Consultancy Agreement

ir.motifbio.com

 NOXXON issues first tranche of ODIRNANE bonds

www.noxxon.com

4SC licenses Kv1.3 inhibitors to Maruho

www.4sc.com

RedHill Biopharma Announces Last Patient Visit in BEKINDA(R) Phase II Study for IBS-D

www.redhillbio.com

ABIVAX to present latest clinical data on ABX464 at the International Aids Society Conference in Paris, France

www.abivax.com

WILEX reports first half 2017 results

www.wilex.de

RedHill Announces Expected Timeline for DSMB meeting and Provides Update on Enrollment in the RHB-104 Phase III Study for Crohn’s Disease

www.redhillbio.com

New Experimental Data on Anti-inflammatory Effects of ABX464, ABIVAX’s First-in-Class Drug Candidate to Achieve Functional Cure in HIV-Patients, Published in Nature Scientific Reports

www.abivax.com

NOXXON Pharma announces prospectus publication and share transfer to the public offering compartment of the EuroNext Growth market

www.noxxon.com

Creathor Venture invests in AI-enabled clinical genetic testing company Blueprint Genetics as part of an up to EUR 14 million financing round

www.creathor.com